Exact Mass: 429.19399820000007
Exact Mass Matches: 429.19399820000007
Found 159 metabolites which its exact mass value is equals to given mass value 429.19399820000007
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Abiraterone sulfate
C24H31NO4S (429.19736860000006)
Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
Hippuryl-histidyl-leucine
C21H27N5O5 (429.20120920000005)
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
C27H27NO4 (429.19399820000007)
8-Benzylcanadine
C27H27NO4 (429.19399820000007)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
Ala Asp Pro Gln
C17H27N5O8 (429.18595419999997)
Ala Asp Gln Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Asn Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Pro Asn
C17H27N5O8 (429.18595419999997)
Ala Gly Pro Trp
C21H27N5O5 (429.20120920000005)
Ala Gly Trp Pro
C21H27N5O5 (429.20120920000005)
Ala Asn Glu Pro
C17H27N5O8 (429.18595419999997)
Ala Asn Pro Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Asp Gln
C17H27N5O8 (429.18595419999997)
Ala Pro Glu Asn
C17H27N5O8 (429.18595419999997)
Ala Pro Gly Trp
C21H27N5O5 (429.20120920000005)
Ala Pro Asn Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Gln Asp
C17H27N5O8 (429.18595419999997)
Ala Pro Trp Gly
C21H27N5O5 (429.20120920000005)
Ala Gln Asp Pro
C17H27N5O8 (429.18595419999997)
Ala Gln Pro Asp
C17H27N5O8 (429.18595419999997)
Ala Trp Gly Pro
C21H27N5O5 (429.20120920000005)
Ala Trp Pro Gly
C21H27N5O5 (429.20120920000005)
Asp Ala Pro Gln
C17H27N5O8 (429.18595419999997)
Asp Ala Gln Pro
C17H27N5O8 (429.18595419999997)
Asp Pro Ala Gln
C17H27N5O8 (429.18595419999997)
Asp Pro Gln Ala
C17H27N5O8 (429.18595419999997)
Asp Gln Ala Pro
C17H27N5O8 (429.18595419999997)
Asp Gln Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Ala Asn Pro
C17H27N5O8 (429.18595419999997)
Glu Ala Pro Asn
C17H27N5O8 (429.18595419999997)
Glu Gly Pro Gln
C17H27N5O8 (429.18595419999997)
Glu Gly Gln Pro
C17H27N5O8 (429.18595419999997)
Glu Asn Ala Pro
C17H27N5O8 (429.18595419999997)
Glu Asn Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Ala Asn
C17H27N5O8 (429.18595419999997)
Glu Pro Gly Gln
C17H27N5O8 (429.18595419999997)
Glu Pro Asn Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Gln Gly
C17H27N5O8 (429.18595419999997)
Glu Gln Gly Pro
C17H27N5O8 (429.18595419999997)
Glu Gln Pro Gly
C17H27N5O8 (429.18595419999997)
Gly Ala Pro Trp
C21H27N5O5 (429.20120920000005)
Gly Ala Trp Pro
C21H27N5O5 (429.20120920000005)
Gly Glu Pro Gln
C17H27N5O8 (429.18595419999997)
Gly Glu Gln Pro
C17H27N5O8 (429.18595419999997)
Gly Pro Ala Trp
C21H27N5O5 (429.20120920000005)
Gly Pro Glu Gln
C17H27N5O8 (429.18595419999997)
Gly Pro Gln Glu
C17H27N5O8 (429.18595419999997)
Gly Pro Trp Ala
C21H27N5O5 (429.20120920000005)
Gly Gln Glu Pro
C17H27N5O8 (429.18595419999997)
Gly Gln Pro Glu
C17H27N5O8 (429.18595419999997)
Gly Trp Ala Pro
C21H27N5O5 (429.20120920000005)
Gly Trp Pro Ala
C21H27N5O5 (429.20120920000005)
Asn Ala Glu Pro
C17H27N5O8 (429.18595419999997)
Asn Ala Pro Glu
C17H27N5O8 (429.18595419999997)
Asn Glu Ala Pro
C17H27N5O8 (429.18595419999997)
Asn Glu Pro Ala
C17H27N5O8 (429.18595419999997)
Asn Pro Ala Glu
C17H27N5O8 (429.18595419999997)
Asn Pro Glu Ala
C17H27N5O8 (429.18595419999997)
Pro Ala Asp Gln
C17H27N5O8 (429.18595419999997)
Pro Ala Glu Asn
C17H27N5O8 (429.18595419999997)
Pro Ala Gly Trp
C21H27N5O5 (429.20120920000005)
Pro Ala Asn Glu
C17H27N5O8 (429.18595419999997)
Pro Ala Gln Asp
C17H27N5O8 (429.18595419999997)
Pro Ala Trp Gly
C21H27N5O5 (429.20120920000005)
Pro Asp Ala Gln
C17H27N5O8 (429.18595419999997)
Pro Asp Gln Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Ala Asn
C17H27N5O8 (429.18595419999997)
Pro Glu Gly Gln
C17H27N5O8 (429.18595419999997)
Pro Glu Asn Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Gln Gly
C17H27N5O8 (429.18595419999997)
Pro Gly Ala Trp
C21H27N5O5 (429.20120920000005)
Pro Gly Glu Gln
C17H27N5O8 (429.18595419999997)
Pro Gly Gln Glu
C17H27N5O8 (429.18595419999997)
Pro Gly Trp Ala
C21H27N5O5 (429.20120920000005)
Pro Asn Ala Glu
C17H27N5O8 (429.18595419999997)
Pro Asn Glu Ala
C17H27N5O8 (429.18595419999997)
Pro Gln Ala Asp
C17H27N5O8 (429.18595419999997)
Pro Gln Asp Ala
C17H27N5O8 (429.18595419999997)
Pro Gln Glu Gly
C17H27N5O8 (429.18595419999997)
Pro Gln Gly Glu
C17H27N5O8 (429.18595419999997)
Pro Trp Ala Gly
C21H27N5O5 (429.20120920000005)
Pro Trp Gly Ala
C21H27N5O5 (429.20120920000005)
Gln Ala Asp Pro
C17H27N5O8 (429.18595419999997)
Gln Ala Pro Asp
C17H27N5O8 (429.18595419999997)
Gln Asp Ala Pro
C17H27N5O8 (429.18595419999997)
Gln Asp Pro Ala
C17H27N5O8 (429.18595419999997)
Gln Glu Gly Pro
C17H27N5O8 (429.18595419999997)
Gln Glu Pro Gly
C17H27N5O8 (429.18595419999997)
Gln Gly Glu Pro
C17H27N5O8 (429.18595419999997)
Gln Gly Pro Glu
C17H27N5O8 (429.18595419999997)
Gln Pro Ala Asp
C17H27N5O8 (429.18595419999997)
Gln Pro Asp Ala
C17H27N5O8 (429.18595419999997)
Gln Pro Glu Gly
C17H27N5O8 (429.18595419999997)
Gln Pro Gly Glu
C17H27N5O8 (429.18595419999997)
Trp Ala Gly Pro
C21H27N5O5 (429.20120920000005)
Trp Ala Pro Gly
C21H27N5O5 (429.20120920000005)
Trp Gly Ala Pro
C21H27N5O5 (429.20120920000005)
Trp Gly Pro Ala
C21H27N5O5 (429.20120920000005)
Trp Pro Ala Gly
C21H27N5O5 (429.20120920000005)
Trp Pro Gly Ala
C21H27N5O5 (429.20120920000005)
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
C27H27NO4 (429.19399820000007)
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C25H27N5S (429.19870620000006)
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
C21H32ClNO6 (429.19180420000004)
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
(1R,9S,10S,11S)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
(1S,9R,10R,11R)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate
C24H31NO4S (429.19736860000006)
4F 4PP (oxalate)
C24H28FNO5 (429.19514100000004)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].